GO:0045542 positive regulation of cholesterol biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045542 describes any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol.
• The term is a biological_process child of cholesterol biosynthetic process regulation and is central to lipid homeostasis, membrane biogenesis and steroid hormone production.
• Key upstream regulators include SREBP2-SCAP-INSIG sensing of sterols, mTORC1-driven glutamine sensing, and post-translational modifications such as S-acylation and delactylation.
• Dysregulation of cholesterol biosynthesis is implicated in hepatocellular carcinoma immune escape, clear cell renal cell carcinoma progression, T cell antitumor immunity and cognitive disorders.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect causal roles of SCAP, SQLE, SCARB1, HMGCR and related genes in this process.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study positive regulation of cholesterol biosynthetic process.
Description
Cholesterol is an essential lipid required for membrane integrity, lipid raft formation, steroid hormone synthesis and bile acid production. The Gene Ontology term GO:0045542, positive regulation of cholesterol biosynthetic process, captures any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol. This term is a biological_process node that sits downstream of sterol-sensing and nutrient-sensing pathways and is critical for understanding how cells adapt to changing lipid demands. Researchers study GO:0045542 because its dysregulation contributes to cancer immune evasion, metabolic disease and neurodegeneration. The process is controlled by a network of transcription factors, post-translational modifiers and transport proteins that together determine whether cells synthesize cholesterol de novo or import it from the environment. Understanding the positive regulation of cholesterol biosynthesis at the molecular level enables the design of targeted interventions for cancer, immune disorders and cognitive decline.
positive regulation of cholesterol biosynthetic process At A Glance
| GO ID | GO:0045542 |
|---|---|
| GO term | positive regulation of cholesterol biosynthetic process |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol. |
| Synonyms | activation of cholesterol biosynthetic process; positive regulation of cholesterol anabolism; positive regulation of cholesterol biosynthesis; positive regulation of cholesterol formation; positive regulation of cholesterol synthesis; stimulation of cholesterol biosynthetic process; up regulation of cholesterol biosynthetic process; up-regulation of cholesterol biosynthetic process; upregulation of cholesterol biosynthetic process |
| Major function | Upregulation of the mevalonate pathway and cholesterol synthesis in response to cellular demand. |
| Related processes | SREBP2 activation, SCAP-INSIG sterol sensing, mTORC1 signaling, post-translational modifications of cholesterol enzymes. |
| Disease relevance | Hepatocellular carcinoma, clear cell renal cell carcinoma, T cell immunity, cognitive disorders. |
What Is GO:0045542?
GO:0045542 is defined by QuickGO as any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of cholesterol. In practical terms, it encompasses the upstream signaling events, transcriptional programs and post-translational modifications that elevate the activity of the mevalonate pathway and its downstream enzymes, leading to increased cholesterol synthesis. This term is distinct from the biosynthetic process itself because it specifically describes the regulatory inputs that positively modulate cholesterol production.
Why Is positive regulation of cholesterol biosynthetic process Important in Cell Biology?
Positive regulation of cholesterol biosynthetic process is fundamental to cellular lipid homeostasis and is hijacked in multiple diseases. In cancer, tumor cells often upregulate cholesterol synthesis to support rapid proliferation and to evade immune detection. In immunology, cholesterol availability influences T cell activation and antitumor immunity. In neuroscience, altered cholesterol metabolism is linked to cognitive impairment. Therefore, understanding GO:0045542 provides mechanistic insight into disease pathogenesis and identifies potential therapeutic targets.
• Controls membrane fluidity and lipid raft signaling by adjusting cholesterol supply.
• Supports rapid proliferation of cancer cells through enhanced mevalonate pathway flux.
• Modulates immune cell function, including CD8+ T cell antitumor activity.
• Links nutrient sensing (glutamine, sterols) to lipid synthesis.
• Influences intestinal immune responses and dietary lipid absorption.
• Contributes to liver cancer growth via PD-L1 delactylation and SQLE transcription.
• Promotes tumor immune escape in hepatocellular carcinoma through SCAP S-acylation.
• Drives clear cell renal cell carcinoma progression via SCARB1 stabilization.
• Implicated in cognitive decline and Alzheimer's disease risk.
• Provides targets for CRISPR-based functional genomics and drug discovery.
What Happens During positive regulation of cholesterol biosynthetic process?
Sterol sensing and SREBP2 activation
In simple terms: When cells need more cholesterol, they activate a master transcription factor called SREBP2.
The positive regulation of cholesterol biosynthesis begins with sensing of low sterol levels in the endoplasmic reticulum. SCAP, a sterol-sensing escort protein, undergoes S-acylation mediated by ZDHHC3, which promotes its interaction with SREBP2 and facilitates SREBP2 translocation to the Golgi for activation. This activation leads to increased transcription of mevalonate pathway genes, thereby upregulating cholesterol synthesis.
Glutamine sensing and mTORC1 signaling
In simple terms: Cells use nutrients like glutamine as a signal to turn on cholesterol production.
Glutamine availability is sensed by mTORC1, which licenses cholesterol synthesis by promoting the processing and activation of SREBP2. This links amino acid metabolism to lipid biosynthesis, ensuring that cholesterol production is coordinated with overall nutrient status.
Post-translational modifications of cholesterol enzymes
In simple terms: Chemical tags on cholesterol-making enzymes can change how active they are.
PD-L1 delactylation promotes its nuclear translocation, where it elevates SQLE transcription activity, thereby enhancing cholesterol biosynthesis in liver cancer. This exemplifies how post-translational modifications and non-canonical protein functions can positively regulate the pathway.
Transcriptional and post-transcriptional control of transport proteins
In simple terms: Proteins that import cholesterol can also be stabilized to boost the pathway.
CircABCA1 promotes clear cell renal cell carcinoma by reprogramming cholesterol metabolism and facilitating M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA. This highlights how RNA-binding proteins and circular RNAs can positively regulate cholesterol biosynthesis and transport.
T cell cholesterol transport and immune modulation
In simple terms: How immune cells handle cholesterol affects intestinal immunity.
T cell cholesterol transport links intestinal immune responses to dietary lipid absorption, indicating that positive regulation of cholesterol biosynthesis in T cells can influence systemic lipid handling. This connection underscores the broader physiological impact of the pathway.
Key Genes Involved in GO:0045542 positive regulation of cholesterol biosynthetic process
The following genes and proteins are experimentally implicated in the positive regulation of cholesterol biosynthetic process, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SCAP | Sterol-sensing escort protein; S-acylation promotes SREBP2 activation | Target for HCC immune escape studies |
| SREBP2 | Master transcription factor for mevalonate pathway genes | Central node in cholesterol biosynthesis regulation |
| SQLE | Squalene epoxidase, rate-limiting enzyme in cholesterol synthesis | Transcriptional target of PD-L1; liver cancer growth |
| SCARB1 | Scavenger receptor class B member 1; cholesterol uptake | Stabilized by IGF2BP3 in ccRCC |
| HMGCR | HMG-CoA reductase, rate-limiting enzyme of mevalonate pathway | Classic target of statins; regulated by SREBP2 |
| ZDHHC3 | Palmitoyltransferase that S-acylates SCAP | Promotes cholesterol biosynthesis and tumor immune escape |
| PD-L1 | Immune checkpoint protein; delactylation promotes nuclear translocation | Elevates SQLE transcription in liver cancer |
| IGF2BP3 | RNA-binding protein that stabilizes SCARB1 mRNA | Promotes ccRCC progression |
| CircABCA1 | Circular RNA that reprograms cholesterol metabolism | Facilitates M2 macrophage polarization in ccRCC |
| mTORC1 | Nutrient sensor kinase | Licenses cholesterol synthesis via glutamine sensing |
| INSIG | Endoplasmic reticulum protein that retains SCAP-SREBP2 | Negative regulator of SREBP2 processing |
| LDLR | Low-density lipoprotein receptor | Supplies cholesterol; feedback regulated by SREBP2 |
| ABCA1 | Cholesterol efflux transporter | Related to circABCA1 function in ccRCC |
| CD8+ T cells | Immune effector cells | Cholesterol biosynthesis supports antitumor immunity |
| tRNA m1A modification | Epitranscriptomic mark | Regulates cholesterol biosynthesis in CD8+ T cells |
| Trans fatty acids | Dietary lipids | Modulate cholesterol metabolism |
| Glutamine | Amino acid | Sensed by mTORC1 to license cholesterol synthesis |
How Is positive regulation of cholesterol biosynthetic process Regulated?
The positive regulation of cholesterol biosynthetic process is controlled by a multilayered regulatory network. Sterol levels are sensed by SCAP-INSIG, which determines SREBP2 processing and transcriptional output. Nutrient availability, particularly glutamine, is integrated via mTORC1 signaling to license cholesterol synthesis. Post-translational modifications such as S-acylation of SCAP and delactylation of PD-L1 further modulate pathway activity. Additionally, RNA-binding proteins like IGF2BP3 stabilize mRNAs of cholesterol transport proteins, adding another layer of post-transcriptional control. Dietary factors, including trans fatty acids, can also influence cholesterol metabolism.
positive regulation of cholesterol biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCAP | Hepatocellular carcinoma immune escape | KO or point-mutation in HCC cell lines |
| SQLE | Liver cancer growth | Overexpression or knockout in hepatoma cells |
| SCARB1 | Clear cell renal cell carcinoma | Knock-in of stabilization mutations in ccRCC cells |
| CD8+ T cells | Antitumor immunity | CRISPR knockout of tRNA m1A writers in primary T cells |
| HMGCR | Cognitive disorders | Neuron-specific knockout or overexpression |
Hepatocellular carcinoma (HCC)
In HCC, ZDHHC3-mediated S-acylation of SCAP promotes cholesterol biosynthesis and tumor immune escape. PD-L1 delactylation enhances SQLE transcription, accelerating liver cancer growth. These findings link positive regulation of cholesterol biosynthesis to HCC progression and immune evasion.
Clear cell renal cell carcinoma (ccRCC)
CircABCA1 reprograms cholesterol metabolism and facilitates M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA, promoting ccRCC progression. This highlights the role of cholesterol biosynthesis regulation in kidney cancer.
Antitumor immunity
tRNA m1A modification regulates cholesterol biosynthesis to promote antitumor immunity of CD8+ T cells. T cell cholesterol transport also links intestinal immune responses to dietary lipid absorption. Thus, positive regulation of cholesterol biosynthesis is critical for effective immune responses.
Cognitive disorders
Lipids and cognition are closely linked, with cholesterol metabolism implicated in Alzheimer's disease and cognitive decline. Dysregulation of cholesterol biosynthesis may contribute to neurodegeneration.
From positive regulation of cholesterol biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SCAP S-acylation drive cholesterol biosynthesis? | Point-mutation knock-in of SCAP acylation sites |
| Is SQLE required for liver cancer growth? | CRISPR knockout of SQLE in HCC cell lines |
| Does SCARB1 stabilization promote ccRCC? | Knock-in of IGF2BP3 binding sites in SCARB1 3'UTR |
| How does tRNA m1A modification affect CD8+ T cell immunity? | Knockout of m1A writers in primary T cells |
| Can overexpression of SREBP2 increase cholesterol synthesis? | Doxycycline-inducible SREBP2 overexpression |
| What is the role of glutamine sensing in cholesterol synthesis? | mTORC1 knockout or glutamine deprivation |
How to Study the positive regulation of cholesterol biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript levels of cholesterol biosynthesis genes | Assess SREBP2 target activation |
| Proteomics | Protein abundance and modifications | Detect SCAP S-acylation |
| Lipidomics | Cholesterol and intermediate levels | Validate pathway flux |
| CRISPR knockout screen | Gene essentiality for cholesterol synthesis | Identify novel regulators |
| ChIP-seq | SREBP2 binding to target promoters | Map transcriptional regulation |
| Immunoprecipitation | Protein-protein interactions | Study SCAP-SREBP2 complex |
| Metabolic flux analysis | De novo cholesterol synthesis rate | Quantify pathway activity |
Transcriptomic profiling
RNA-seq can quantify expression of mevalonate pathway genes such as HMGCR, SQLE and SREBP2 targets after genetic or pharmacological perturbation. This reveals transcriptional changes underlying positive regulation of cholesterol biosynthesis.
Proteomic and post-translational modification analysis
Mass spectrometry-based proteomics can detect S-acylation of SCAP or delactylation of PD-L1, providing mechanistic insight into post-translational regulation.
Lipidomics and cholesterol quantification
Direct measurement of cholesterol and intermediates by mass spectrometry or enzymatic assays validates functional changes in cholesterol biosynthesis.
CRISPR screens
Genome-wide CRISPR knockout or activation screens can identify novel regulators of cholesterol biosynthesis under specific conditions, such as immune pressure or nutrient stress.
How CRISPR Can Be Used to Study GO:0045542 positive regulation of cholesterol biosynthetic process
Knockout
CRISPR knockout of SCAP, SQLE or HMGCR can abolish positive regulation of cholesterol biosynthesis, revealing essential genes and their contribution to disease phenotypes such as tumor growth.
Point Mutation
Point mutations can be introduced to disrupt specific post-translational modification sites, such as SCAP S-acylation sites, to test their role in cholesterol biosynthesis and immune escape.
Knock-in
Knock-in of tagged or mutant alleles, such as SCARB1 3'UTR mutations that affect IGF2BP3 binding, allows precise dissection of post-transcriptional regulation.
Overexpression
Overexpression of SREBP2 or SQLE via CRISPR activation or cDNA delivery can drive cholesterol biosynthesis and model gain-of-function phenotypes in cancer.
How EDITGENE Supports positive regulation of cholesterol biosynthetic process Research
Researchers studying positive regulation of cholesterol biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with its activity. EDITGENE provides validated CRISPR cell models and screening services to establish causality and mechanism.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of cholesterol biosynthetic process research.
Frequently Asked Questions About positive regulation of cholesterol biosynthetic process
What is GO:0045542?
GO:0045542 is the Gene Ontology term for positive regulation of cholesterol biosynthetic process, defined as any process that activates or increases the frequency, rate or extent of cholesterol formation.
What genes are involved in positive regulation of cholesterol biosynthetic process?
Key genes include SCAP, SREBP2, SQLE, SCARB1, HMGCR, ZDHHC3 and PD-L1, as shown in recent literature.
How is cholesterol biosynthesis regulated?
It is regulated by sterol sensing via SCAP-INSIG, nutrient sensing via mTORC1, and post-translational modifications such as S-acylation and delactylation.
What diseases are linked to cholesterol biosynthesis dysregulation?
Cancers such as hepatocellular carcinoma and clear cell renal cell carcinoma, as well as cognitive disorders and immune dysfunction.
What research methods are used to study cholesterol biosynthesis?
RNA-seq, proteomics, lipidomics, CRISPR screens and metabolic flux analysis are commonly used.
How can CRISPR help study positive regulation of cholesterol biosynthesis?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of genes in the pathway.
What is the role of SCAP in cholesterol biosynthesis?
SCAP is a sterol-sensing protein that escorts SREBP2; its S-acylation promotes cholesterol biosynthesis and tumor immune escape.
How does glutamine affect cholesterol synthesis?
Glutamine sensing via mTORC1 licenses cholesterol synthesis by promoting SREBP2 activation.
Is cholesterol biosynthesis important for immune cells?
Yes, it supports CD8+ T cell antitumor immunity and links intestinal immune responses to dietary lipid absorption.
What services does EDITGENE offer for cholesterol biosynthesis research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening and bioinformatics services.
Conclusion
GO:0045542 positive regulation of cholesterol biosynthetic process is a critical biological process that integrates nutrient sensing, transcriptional control and post-translational modifications to meet cellular cholesterol demand. Its dysregulation contributes to cancer progression, immune evasion and cognitive disorders. CRISPR-based models and multi-omics approaches are essential to dissect its mechanisms and identify therapeutic targets. EDITGENE offers comprehensive services to accelerate this research.
References
- 1. Oteng AB et al.. 2020. Mechanisms of Action of trans Fatty Acids.. Adv Nutr 11(3):697-708 PMID: 31782488
- 2. Wang X et al.. 2025. PD-L1 delactylation-promoted nuclear translocation accelerates liver cancer growth through elevating SQLE transcription activity.. Cancer Lett 630:217901 PMID: 40614853
- 3. Gao Y et al.. 2025. T cell cholesterol transport links intestinal immune responses to dietary lipid absorption.. Science 390(6769):eadt4169 PMID: 41066556
- 4. Garcia BM et al.. 2024. Glutamine sensing licenses cholesterol synthesis.. EMBO J 43(23):5837-5856 PMID: 39433901
- 5. Wu M et al.. 2024. ZDHHC3-mediated SCAP S-acylation promotes cholesterol biosynthesis and tumor immune escape in hepatocellular carcinoma.. Cell Rep 43(11):114962 PMID: 39522165
- 6. Ning H et al.. 2025. CircABCA1 promotes ccRCC by reprogramming cholesterol metabolism and facilitating M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA.. Mol Cancer 24(1):199 PMID: 40684174
- 7. Miao S et al.. 2025. tRNA m1A modification regulates cholesterol biosynthesis to promote antitumor immunity of CD8+ T cells.. J Exp Med 222(3) PMID: 39873720
- 8. Morley JE et al.. 2010. Lipids and cognition.. J Alzheimers Dis 20(3):737-47 PMID: 20413879
